Seer Inc. stocks have been trading up by 37.65 percent amid heightened optimism from its latest breakthrough technology announcement.
Click Here for a Millionaire's POV on Trading SEER
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- Seer’s CEO proposed a management-led buyout at $2.45 per share plus two CVRs, with a Special Committee now reviewing the offer and any alternatives.
- An activist group holding 7.7% of Seer is pushing to replace the chair/CEO and two directors after a 97% share-price collapse, heavy losses, and a poison pill.
- The same activists say Seer’s board rejected three premium acquisition offers and forecast profitability only by 2031, questioning leadership’s ability to create value.
- Seer defended a core European patent and drove a U.S. ITC action against Nanomics, aiming to block allegedly infringing Proteonano products tied to its Proteograph platform.
- Early data from a Korea University collaboration suggest Seer’s Proteograph plus AI framework may support future multi-cancer screening across ten major cancer types.
Live Update At 10:03:50 EDT: On Monday, July 06, 2026 Seer Inc. stock [NASDAQ: SEER] is trending up by 37.65%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
SEER has turned into a volatility magnet. The stock sat stuck around $1.66–$1.74 for weeks, then exploded to a $2.23 close on 2026/07/06. That’s roughly a 35% jump from late-June levels, a clear sign traders are suddenly pricing in event risk around Seer Inc.
Intraday, SEER has been a clean momentum playground. On the latest session, premarket action walked the stock up from about $2.03 to above $2.20, then regular-hours trading spiked it to $2.28 before some fade. That kind of range gives active traders room, but also demands tight risk control.
More Breaking News
- Bloom Energy Stock Jumps As Brookfield Boosts $25B AI Power Deal
- AVAV Stock Soars As Record Quarter, Army Deal Shift Momentum
- BTBT Stock Steadies As Traders Focus On Tight Range
- SHAZ Stock Jumps As SharonAI Locks In Massive NVIDIA Deal
Fundamentally, Seer Inc. is still bleeding cash. Q1 2026 revenue was only about $2.8M, while net loss came in near $16.8M. Margins are brutal: EBIT margin is roughly -465%, with return on equity deeply negative. At the same time, SEER shows a huge cash cushion and almost no leverage. Current ratio around 17.7 and minimal debt mean the balance sheet is strong, even as operations burn about $15.4M in a quarter. For traders, that mix—massive losses but solid cash—often fuels speculative runs around deals, patents, or buyouts.
Why Traders Are Watching Seer Inc. Right Now
SEER is in the middle of a full-blown corporate showdown, and that’s exactly the kind of setup short-term traders hunt. On 2026/07/02, Seer Inc. disclosed an unsolicited, non-binding management buyout proposal from Chair and CEO Omid Farokhzad. The offer: $2.45 per share in cash plus two contingent value rights tied to future outcomes. With SEER closing near $2.23 on 2026/07/06, that headline effectively set a near-term valuation anchor just above the market.
The board of Seer formed a Special Committee of independent directors to review the bid and any alternatives. That move matters. It opens the door to a formal process with three main paths: a negotiated deal at or above $2.45, a higher competing offer, or no transaction at all. Every press release from that committee now becomes a potential trading catalyst for SEER.
At the same time, Seer Inc. is battling an aggressive activist campaign. Bradley Radoff, Michael Torok, and their group control roughly 7.7% of SEER and are pushing to oust the current chair/CEO and two directors. They’re pointing to a 97% share-price collapse since the 2020 IPO, more than $465M in cumulative losses, and very limited revenue growth. They also claim the Seer board previously rejected three premium acquisition offers and only sees profitability out in 2031.
That governance fight creates serious event risk around SEER—proxy votes, board changes, or a forced strategic review. Add in Seer’s IP wins at the European Patent Office and a U.S. ITC investigation targeting Nanomics, plus promising early multi-cancer screening data with Korea University, and you have a classic tension: strong technology platform, weak track record in value creation. Traders are crowding into SEER to play that disconnect.
Conclusion
For active traders, SEER is now a pure catalyst story. On one side, Seer Inc. is showing real scientific traction: the Proteograph Product Suite, protected by defended patents, and early signals that its tech plus an AI framework may support multi-cancer screening. That gives the SEER equity a strategic backbone that potential acquirers and long-term capital care about.
On the other side, the numbers show deep value destruction. Seer Inc. has logged over $465M in cumulative losses, posted a Q1 2026 net loss of about $16.8M on just $2.8M in revenue, and trades at roughly half of book value. That backdrop explains why activists are attacking the current Seer leadership and why a management-led buyout at $2.45 per share is facing heavy scrutiny.
For traders, the key is to treat SEER as an event-driven, rule-based setup—never a long-term safety play. Track headlines from the Seer Special Committee, any activist proxy updates, and new IP or clinical data. Be ready for gaps both ways. As Tim Sykes loves to say, “Volatility is opportunity, but only if you respect your risk and cut losses quickly.” And as Tim Bohen, lead trainer with StocksToTrade says, “A good trade setup checks all the boxes—volume, trend, catalyst. Don’t trade if you’re missing pieces of the puzzle.”. SEER now fits that description perfectly, making it a ticker to watch closely—but always through a disciplined, trading-first lens.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.